Pre-order Enquiry
Request Free Sample
Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15133626 | Publishing Date : 28-Jan-2020 | No. of pages : 93
Detailed TOC of Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Crizotinib
1.4.3 Alectinib
1.4.4 Ceritinib
1.4.5 Brigatinib
1.4.6 Other
1.5 Market by Application
1.5.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 ALK Positive Lung Cancer Treatment Market Perspective (2015-2026)
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 ALK Positive Lung Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key ALK Positive Lung Cancer Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top ALK Positive Lung Cancer Treatment Players by Market Size
3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.2.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2019
3.3 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.4 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
3.5 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application (2015-2026)
5.1 Global ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2015-2020)
6.2 ALK Positive Lung Cancer Treatment Key Players in North America (2019-2020)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
6.4 North America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2015-2020)
7.2 ALK Positive Lung Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
8 China
8.1 China ALK Positive Lung Cancer Treatment Market Size (2015-2020)
8.2 ALK Positive Lung Cancer Treatment Key Players in China (2019-2020)
8.3 China ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
8.4 China ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan ALK Positive Lung Cancer Treatment Market Size (2015-2020)
9.2 ALK Positive Lung Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia ALK Positive Lung Cancer Treatment Market Size (2015-2020)
10.2 ALK Positive Lung Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
11 India
11.1 India ALK Positive Lung Cancer Treatment Market Size (2015-2020)
11.2 ALK Positive Lung Cancer Treatment Key Players in India (2019-2020)
11.3 India ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
11.4 India ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America ALK Positive Lung Cancer Treatment Market Size (2015-2020)
12.2 ALK Positive Lung Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
13Key Players Profiles
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
13.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
13.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
13.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 TP Therapeutics
13.4.1 TP Therapeutics Company Details
13.4.2 TP Therapeutics Business Overview and Its Total Revenue
13.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
13.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.4.5 TP Therapeutics Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
13.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Details
13.6.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
13.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.6.5 Eli Lilly and Company Recent Development
13.7 Takeda
13.7.1 Takeda Company Details
13.7.2 Takeda Business Overview and Its Total Revenue
13.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
13.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.7.5 Takeda Recent Development
13.8 Beacon Pharma
13.8.1 Beacon Pharma Company Details
13.8.2 Beacon Pharma Business Overview and Its Total Revenue
13.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
13.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
13.8.5 Beacon Pharma Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
List of TablesTable 1. ALK Positive Lung Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
Table 3. Ranking of Global Top ALK Positive Lung Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Crizotinib
Table 6. Key Players of Alectinib
Table 7. Key Players of Ceritinib
Table 8. Key Players of Brigatinib
Table 9. Key Players of Other
Table 10. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global ALK Positive Lung Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global ALK Positive Lung Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2015-2020)
Table 14. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. ALK Positive Lung Cancer Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key ALK Positive Lung Cancer Treatment Players
Table 21. Global ALK Positive Lung Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global ALK Positive Lung Cancer Treatment Market Share by Players (2015-2020)
Table 23. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2019)
Table 24. Global ALK Positive Lung Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
Table 27. Date of Enter into ALK Positive Lung Cancer Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size Share by Type (2015-2020)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2015-2020)
Table 33. Global ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 47. China Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 49. China ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 51. China ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 55. Japan ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 57. Japan ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 61. Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 65. India Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 67. India ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 69. India ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020)
Table 73. Central & South America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020)
Table 75. Central & South America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020)
Table 77. F. Hoffmann-La Roche Company Details
Table 78. F. Hoffmann-La Roche Business Overview
Table 79. F. Hoffmann-La Roche Product
Table 80. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 81. F. Hoffmann-La Roche Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. TP Therapeutics Company Details
Table 93. TP Therapeutics Business Overview
Table 94. TP Therapeutics Product
Table 95. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 96. TP Therapeutics Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Product
Table 100. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Product
Table 105. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 106. Eli Lilly and Company Recent Development
Table 107. Takeda Company Details
Table 108. Takeda Business Overview
Table 109. Takeda Product
Table 110. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 111. Takeda Recent Development
Table 112. Beacon Pharma Business Overview
Table 113. Beacon Pharma Product
Table 114. Beacon Pharma Company Details
Table 115. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 116. Beacon Pharma Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Crizotinib Features
Figure 3. Alectinib Features
Figure 4. Ceritinib Features
Figure 5. Brigatinib Features
Figure 6. Other Features
Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 12. Global ALK Positive Lung Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global ALK Positive Lung Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2019
Figure 17. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2019
Figure 19. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 32. TP Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 34. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 38. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 40. Beacon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Keyplayers in Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
F. Hoffmann-La RochePfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Request Sample
Request Discount
